Genome Editing Technologies: Defining a Path to Clinic
Main Authors: | Corrigan-Curay, Jacqueline, O'Reilly, Marina, Kohn, Donald B, Cannon, Paula M, Bao, Gang, Bushman, Frederic D, Carroll, Dana, Cathomen, Toni, Joung, J Keith, Roth, David, Sadelain, Michel, Scharenberg, Andrew M, von Kalle, Christof, Zhang, Feng, Jambou, Robert, Rosenthal, Eugene, Hassani, Morad, Singh, Aparna, Porteus, Matthew H |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Article |
Published: |
Elsevier BV
2017
|
Online Access: | http://hdl.handle.net/1721.1/112722 https://orcid.org/0000-0003-2782-2509 |
Similar Items
-
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
by: Cannon, Paula, et al.
Published: (2021) -
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
by: Cannon, Paula, et al.
Published: (2022) -
Cellular and molecular characterization of atherothrombosis-related markers in sprague dawley rats fed with high cholesterol diet supplemented with herbal extracts
by: Kwaifa, Ibrahim Kalle
Published: (2021) -
Systems Engineering Confronts Enterprise Change: Frameworks and Lessons from MITRE Projects
by: Carroll, John S., et al.
Published: (2014) -
Applications of forward genetic screens to LncRNAs, cancer immunotherapy, and cellular engineering
by: Joung, Julia.
Published: (2021)